Results of clinical effectiveness of conventional versus Mirasol-treated Apheresis Platelets in Patients with Hypoproliferative Thrombocytopenia (MiPLATE) trial

This study did not support that MIRASOL was non-inferior compared to conventional platelets using the novel endpoint number of days with ≥Grade 2 bleeding in MIRASOL when compared to CONTROL.PMID:38314476 | DOI:10.1111/trf.17720

Source: Transfusion - February 5, 2024 Category: Hematology Authors: Scott A Koepsell Moritz Stolla Rebecca L Sedjo Jeffrey Carson Michael Knudson Richard Cook Ross Fasano Samantha G Ngamsuntikul Claudia Cohn Jed Gorlin Meghan Delaney Sherrill Slichter Paul Ness Jeffrey McCullough Source Type: research